Photonews Logo Photonews logo
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Azad Jammu Kashmir
    • Balochistan
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
    IShowSpeed Daniel La Belle race
    Videos

    IShowSpeed Beats Daniel La Belle in 40-Meter Race, Hits 41M Subscribers

    June 24, 2025 2 Min Read
    Cardi B new single Outside
    Videos

    Cardi B’s ‘Outside’ Single Sparks Buzz Over Offset and Stefon Diggs

    June 20, 2025 2 Min Read
    Squid Game Season 3
    Videos

    Squid Game Season 3: Final Trailer Unveils Epic Plot

    June 14, 2025 2 Min Read
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Reading: Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results
PhotoNews Pakistan PhotoNews Pakistan
Font ResizerAa
Search
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Balochistan
    • Azad Jammu Kashmir
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Have an existing account? Sign In
Follow US
© 2022 Photonews. All Rights Reserved.
Semaglutide Type 1 Diabetes Treatment
PhotoNews Pakistan > Offbeat > Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results
Offbeat

Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results

Web Desk
By Web Desk Published September 9, 2023 3 Min Read
Share
SHARE

Medical researchers are astonished by the potential breakthrough in Type 1 diabetes treatment with the weight loss drug semaglutide, also known under Ozempic and Wegovy. The former is typically used for treating Type 2 diabetes, while the latter is favoured for weight loss. A recent study published in the New England Journal of Medicine divulged remarkable results where most participants, all Type 1 diabetes patients, quit using insulin shots with meals within three months. The study’s lead author, Dr. Paresh Dandona, expressed his disbelief at the rapid progress, likening the results to “science fiction”.

This development could signify a turning point in treating Type 1 diabetes, characterized by the body’s attack on beta cells responsible for insulin production. This is in contrast to Type 2 diabetes, where the body either doesn’t produce enough insulin or resists it, necessitating distinct treatment approaches. The promising results from the semaglutide use could potentially revolutionize the treatment plan for Type 1 diabetes patients, offering a solution to the challenging issue of controlling sugar levels.

Calls for Extensive Further Research

Despite the groundbreaking findings, experts emphasize the necessity for further and larger studies to validate these results. Dr. Dandona remains committed to advancing this potential shift in treatment strategy, with plans to initiate a more extensive study involving collaboration with diabetes investigators nationwide, pending necessary funding.

Other experts in the field share this enthusiasm and urge for substantial research to substantiate these claims. Dr. Michael Natter, an endocrinologist at NYU Langone Health, noted that while the findings are promising, making extensive claims based on a small, non-controlled study would be premature. Echoing this sentiment, Dr. Vanita Aroda, the director of diabetes clinical research at Brigham and Women’s Hospital in Boston, praised the focus on newly diagnosed patients and highlighted the urgent need to explore the potential benefits of such therapies for the larger population of individuals with Type 1 diabetes through comprehensive studies. This collective call for action reflects a cautious optimism in the medical community about the potential transformation in Type 1 diabetes treatment that semaglutide might bring about.

TAGGED:Featured
Share This Article
Facebook Twitter Pinterest Whatsapp Whatsapp LinkedIn Email Copy Link Print
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

HBL Saving Made Easy
HBL Saving Made Easy

Recent Posts

Drake Disses LeBron James on New Track "What Did I Miss?

Drake Disses LeBron James on New Track “What Did I Miss?” from ICEMAN Album

Diogo Jota

Liverpool to Pay Diogo Jota’s Remaining 2 Years Contract to Family

Shadab Khan Shoulder Surgery

Shadab Khan Undergoes Successful Shoulder Surgery

Post Archives

More Popular from Photonews

Meta AI 1 billion users
Tech

Facebook Requests Camera Roll Access for AI-Powered Story Suggestions in 2025

3 Min Read
Cardi B Most Solo Top 10 Hot 100
Entertainment

Cardi B Sets Record as Female Rapper with Most Solo Top 10 Hot 100 Debuts

2 Min Read
Back to the Future 40th
Entertainment

Back to the Future at 40: How It Shaped Pop Culture in 2025

2 Min Read
Entertainment

Julian McMahon, Nip/Tuck and Charmed Star, Dies at 56

On July 2, 2025, Australian actor Julian McMahon, renowned for Nip/Tuck, Charmed, and FBI: Most Wanted,…

July 5, 2025
Top NewsWorld

Saudi FM Prioritizes Gaza Ceasefire Over Israel Ties, Trump Eyes Abraham Accords Expansion

On July 4, 2025, Saudi Arabia’s Foreign Minister Faisal bin Farhan emphasised prioritising a Gaza ceasefire…

July 4, 2025
Pakistan

Field Marshal Asim Munir Honors Captain Karnal Sher Khan on 26th Martyrdom Anniversary

On July 5, 2025, Pakistan’s Armed Forces, led by Chief of Army Staff Field Marshal Syed…

July 5, 2025
Entertainment

Justin Bieber’s Cryptic Instagram Posts Spark Concern for His Well-Being

Justin Bieber’s recent Instagram activity has left fans confused and concerned. The 31-year-old singer shared a…

June 29, 2025
PhotoNews Pakistan

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

Categories

  • World
  • Pakistan
  • Punjab
  • Sindh
  • Khyber Pakhtunkhwa
  • Balochistan
  • Azad Jammu Kashmir

 

  • Top News
  • Business
  • Entertainment
  • Sports
  • Videos
  • Tech
  • Offbeat
  • Blog

© 2024 Phototnews
All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?